Upregulated Expression Level of the Growth Factor, Progranulin, is Associated with the Development of Primary Sjögren's Syndrome

Overview

Journal Exp Ther Med

Specialty Pathology

Date 2014 Oct 8

PMID 25289074

Citations 5

Authors

Ni Zhang

Ning Yang

Qilin Chen

Feng Qiu

Xingfu Li

Affiliations

Soon will be listed here.

Abstract

The aim of the present study was to investigate the expression and effect of progranulin (PGRN) in patients with primary Sjögren's syndrome (pSS). In total, 26 newly diagnosed pSS patients and 26 healthy subjects were enrolled in this study. The serum levels of PGRN and the inflammatory factor, interleukin-6 (IL-6), were detected using ELISA. In addition, the mRNA expression levels of these molecules were detected by quantitative polymerase chain reaction. The serum levels of PGRN and IL-6 in the pSS patients increased significantly compared with the healthy controls (P<0.05). During the remission stages, the levels of PGRN and IL-6 were comparable to those of the healthy controls. The serum level of PGRN in the pSS patients was shown to correlate with that of IL-6 in the pre-treatment and post-treatment stages. PGRN was upregulated in the pSS patients, indicating a possible role of PGRN in the pathogenesis and development of pSS.

Citing Articles

GP88/PGRN Serum Levels Are Associated with Prognosis for Oral Squamous Cell Carcinoma Patients.

Greither T, Steiner T, Bache M, Serrero G, Otto S, Taubert H Biology (Basel). 2021; 10(5).

PMID: 34064411 PMC: 8147813. DOI: 10.3390/biology10050400.

Clinical significance of progranulin correlated with serum soluble Oxford 40 ligand in primary Sjögren's syndrome.

Qi X, Guo H, Sun C, Tian Y, Ding M, Yang Y Medicine (Baltimore). 2020; 99(18):e19967.

PMID: 32358369 PMC: 7440338. DOI: 10.1097/MD.0000000000019967.

Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism.

Gotzl J, Brendel M, Werner G, Parhizkar S, Monasor L, Kleinberger G EMBO Mol Med. 2019; 11(6).

PMID: 31122931 PMC: 6554672. DOI: 10.15252/emmm.201809711.

Progranulin concentration in relation to bone mineral density among obese individuals.

Milajerdi A, Maghbooli Z, Mohammadi F, Hosseini B, Mirzaei K Arch Endocrinol Metab. 2018; 62(2):179-186.

PMID: 29641735 PMC: 10118980. DOI: 10.20945/2359-3997000000022.

Progranulin: A key player in autoimmune diseases.

Jian J, Li G, Hettinghouse A, Liu C Cytokine. 2016; 101:48-55.

PMID: 27527809 PMC: 5303690. DOI: 10.1016/j.cyto.2016.08.007.

References

Kessenbrock K, Frohlich L, Sixt M, Lammermann T, Pfister H, Bateman A . Proteinase 3 and neutrophil elastase enhance inflammation in mice by inactivating antiinflammatory progranulin. J Clin Invest. 2008; 118(7):2438-47. PMC: 2430496. DOI: 10.1172/JCI34694. View

Feng J, Guo F, Jiang B, Zhang Y, Frenkel S, Wang D . Granulin epithelin precursor: a bone morphogenic protein 2-inducible growth factor that activates Erk1/2 signaling and JunB transcription factor in chondrogenesis. FASEB J. 2010; 24(6):1879-92. PMC: 2874481. DOI: 10.1096/fj.09-144659. View

Bateman A, Bennett H . The granulin gene family: from cancer to dementia. Bioessays. 2009; 31(11):1245-54. DOI: 10.1002/bies.200900086. View

Eilertsen G, Nikolaisen C, Becker-Merok A, Nossent J . Interleukin-6 promotes arthritis and joint deformation in patients with systemic lupus erythematosus. Lupus. 2011; 20(6):607-13. DOI: 10.1177/0961203310392432. View

Tang B, Matsuda T, Akira S, Nagata N, Ikehara S, Hirano T . Age-associated increase in interleukin 6 in MRL/lpr mice. Int Immunol. 1991; 3(3):273-8. DOI: 10.1093/intimm/3.3.273. View

Zhu J, Nathan C, Jin W, Sim D, Ashcroft G, Wahl S . Conversion of proepithelin to epithelins: roles of SLPI and elastase in host defense and wound repair. Cell. 2003; 111(6):867-78. DOI: 10.1016/s0092-8674(02)01141-8. View

Fox R, Stern M, Michelson P . Update in Sjögren syndrome. Curr Opin Rheumatol. 2000; 12(5):391-8. DOI: 10.1097/00002281-200009000-00007. View

Grondal G, Gunnarsson I, Ronnelid J, Rogberg S, Klareskog L, Lundberg I . Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol. 2000; 18(5):565-70. View

Hochberg M . Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997; 40(9):1725. DOI: 10.1002/art.1780400928. View

10.

Hrabal R, Chen Z, James S, Bennett H, Ni F . The hairpin stack fold, a novel protein architecture for a new family of protein growth factors. Nat Struct Biol. 1996; 3(9):747-52. DOI: 10.1038/nsb0996-747. View

11.

Tang W, Lu Y, Tian Q, Zhang Y, Guo F, Liu G . The growth factor progranulin binds to TNF receptors and is therapeutic against inflammatory arthritis in mice. Science. 2011; 332(6028):478-84. PMC: 3104397. DOI: 10.1126/science.1199214. View

12.

Tishler M, Yaron I, Shirazi I, Yossipov Y, Yaron M . Increased salivary interleukin-6 levels in patients with primary Sjögren's syndrome. Rheumatol Int. 1999; 18(4):125-7. DOI: 10.1007/s002960050070. View

13.

Naka T, Nishimoto N, Kishimoto T . The paradigm of IL-6: from basic science to medicine. Arthritis Res. 2002; 4 Suppl 3:S233-42. PMC: 3240141. DOI: 10.1186/ar565. View

14.

Suzuki H, Yasukawa K, Saito T, Narazaki M, Hasegawa A, Taga T . Serum soluble interleukin-6 receptor in MRL/lpr mice is elevated with age and mediates the interleukin-6 signal. Eur J Immunol. 1993; 23(5):1078-82. DOI: 10.1002/eji.1830230515. View

15.

Ramos-Casals M, Brito-Zeron P, Font J . The overlap of Sjögren's syndrome with other systemic autoimmune diseases. Semin Arthritis Rheum. 2006; 36(4):246-55. DOI: 10.1016/j.semarthrit.2006.08.007. View

16.

He Z, Ong C, Halper J, Bateman A . Progranulin is a mediator of the wound response. Nat Med. 2003; 9(2):225-9. DOI: 10.1038/nm816. View

17.

Tackey E, Lipsky P, Illei G . Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004; 13(5):339-43. PMC: 2014821. DOI: 10.1191/0961203304lu1023oa. View

18.

Mihara M, Nishimoto N, Ohsugi Y . The therapy of autoimmune diseases by anti-interleukin-6 receptor antibody. Expert Opin Biol Ther. 2005; 5(5):683-90. DOI: 10.1517/14712598.5.5.683. View

19.

Lotz M, Jirik F, Kabouridis P, Tsoukas C, Hirano T, Kishimoto T . B cell stimulating factor 2/interleukin 6 is a costimulant for human thymocytes and T lymphocytes. J Exp Med. 1988; 167(3):1253-8. PMC: 2188869. DOI: 10.1084/jem.167.3.1253. View

20.

Ramos-Casals M, Tzioufas A, Font J . Primary Sjögren's syndrome: new clinical and therapeutic concepts. Ann Rheum Dis. 2004; 64(3):347-54. PMC: 1755414. DOI: 10.1136/ard.2004.025676. View